Physician profile
Jose E Abiseid
NPI 1154391514
$552.59
in general payments reported to CMS, 2019-2025
7 companies · $17.80 in 2025
The $17.80 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $49.34 · 2021: $86.47 · 2022: $38.01 · 2023: $188 · 2025: $17.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $214.27 | 2020-2025 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $141.11 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $69.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.33 | 2019 | |
| Merck Sharp & Dohme LLC | $35.86 | 2019 | |
| Mylan Specialty L.P. | $24.34 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $11.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Abiseid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.